Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers
- First Posted Date
- 2018-08-28
- Last Posted Date
- 2020-09-02
- Lead Sponsor
- Metagone Biotech Inc.
- Target Recruit Count
- 81
- Registration Number
- NCT03650075
- Locations
- 🇨🇳
Taipei Medical University Hospital, Taipei, Taiwan
Assess the Safety and Activity of Combined MG005 and Sorafenib (NEXAVAR®) Treatment With Solid Tumor
- First Posted Date
- 2018-01-23
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Metagone Biotech Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT03406364
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei, Nehu District, Taiwan
News
No news found